In total, the mean of NGAL in patients with psoriasis and skin cancers was significantly higher (p = 0.013) than in patients with skin tumors only (both NMSC and M)(158.1 ng/mL vs. 122.9 ng/mL). This evidence concerns the gene LCN2 and skin neoplasm.